HOOKIPA Pharma IncNASDAQ:HOOKNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.7517
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.7700/ 8
- Ask / Lots0.7800/ 1
- Open / Previous Close0.0000 / 0.7517
- Day Range---
- 52 Week Range
- Volume8,983
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HOOK |
|---|---|---|
| 09:32 ET | 8643 | 0.76 |
| 09:34 ET | 500 | 0.75 |
| 09:39 ET | 170 | 0.76 |
| 09:41 ET | 302 | 0.765 |
| 09:48 ET | 11731 | 0.765 |
| 09:50 ET | 995 | 0.765 |
| 09:54 ET | 500 | 0.7625 |
| 09:56 ET | 3100 | 0.7625 |
| 09:59 ET | 101 | 0.7625 |
| 10:01 ET | 4613 | 0.76 |
| 10:12 ET | 3645 | 0.7558 |
| 10:14 ET | 1550 | 0.769 |
| 10:15 ET | 1100 | 0.769 |
| 10:19 ET | 11404 | 0.7528 |
| 10:21 ET | 2200 | 0.7538 |
| 10:24 ET | 862 | 0.7698 |
| 10:37 ET | 5675 | 0.7613 |
| 10:39 ET | 250 | 0.7613 |
| 10:46 ET | 1374 | 0.7528 |
| 10:48 ET | 100 | 0.7529 |
| 11:02 ET | 800 | 0.7696 |
| 11:06 ET | 627 | 0.76 |
| 11:08 ET | 200 | 0.76 |
| 11:09 ET | 879 | 0.7696 |
| 11:11 ET | 767 | 0.76 |
| 11:18 ET | 8564 | 0.76 |
| 11:20 ET | 1400 | 0.763999 |
| 11:22 ET | 30336 | 0.76 |
| 11:24 ET | 200 | 0.75665 |
| 11:27 ET | 500 | 0.7528 |
| 11:29 ET | 288 | 0.7566 |
| 11:31 ET | 300 | 0.7566 |
| 11:36 ET | 1409 | 0.7585 |
| 11:38 ET | 2200 | 0.7585 |
| 11:40 ET | 2975 | 0.7566 |
| 11:47 ET | 1300 | 0.768 |
| 11:49 ET | 200 | 0.761 |
| 11:56 ET | 6284 | 0.7657 |
| 11:58 ET | 100 | 0.7629 |
| 12:02 ET | 12300 | 0.76 |
| 12:05 ET | 100 | 0.7649 |
| 12:07 ET | 100 | 0.767 |
| 12:09 ET | 3071 | 0.7608 |
| 12:12 ET | 100 | 0.76 |
| 12:18 ET | 400 | 0.76 |
| 12:21 ET | 280 | 0.76 |
| 12:32 ET | 2700 | 0.76 |
| 12:34 ET | 2600 | 0.76 |
| 12:43 ET | 500 | 0.7608 |
| 12:45 ET | 250 | 0.7616 |
| 12:48 ET | 130 | 0.7615 |
| 12:50 ET | 2200 | 0.76 |
| 12:52 ET | 2100 | 0.76 |
| 12:57 ET | 12833 | 0.7566 |
| 01:01 ET | 2307 | 0.7566 |
| 01:06 ET | 645 | 0.7572 |
| 01:08 ET | 356 | 0.7569 |
| 01:19 ET | 11544 | 0.75999 |
| 01:21 ET | 2900 | 0.7574 |
| 01:24 ET | 4500 | 0.7566 |
| 01:26 ET | 300 | 0.7576 |
| 01:28 ET | 100 | 0.7576 |
| 01:32 ET | 2100 | 0.7566 |
| 01:35 ET | 1200 | 0.757 |
| 01:37 ET | 27025 | 0.7466 |
| 01:39 ET | 2730 | 0.7483 |
| 01:42 ET | 4472 | 0.7483 |
| 01:44 ET | 43055 | 0.74 |
| 01:46 ET | 1047 | 0.745 |
| 01:48 ET | 21093 | 0.73 |
| 01:50 ET | 300 | 0.74895 |
| 01:51 ET | 500 | 0.7451 |
| 01:53 ET | 911 | 0.74895 |
| 01:55 ET | 100 | 0.7489 |
| 02:00 ET | 2300 | 0.7351 |
| 02:02 ET | 302 | 0.7449 |
| 02:04 ET | 680 | 0.742449 |
| 02:06 ET | 5266 | 0.74245 |
| 02:08 ET | 654 | 0.7424 |
| 02:09 ET | 500 | 0.7449 |
| 02:15 ET | 200 | 0.7448 |
| 02:18 ET | 2400 | 0.744 |
| 02:22 ET | 1186 | 0.744 |
| 02:24 ET | 771 | 0.744 |
| 02:26 ET | 24241 | 0.74 |
| 02:31 ET | 200 | 0.7401 |
| 02:36 ET | 5800 | 0.745 |
| 02:42 ET | 5613 | 0.7532 |
| 02:45 ET | 1300 | 0.7529 |
| 02:47 ET | 200 | 0.745 |
| 02:54 ET | 750 | 0.7531 |
| 02:56 ET | 132 | 0.7531 |
| 02:58 ET | 100 | 0.7511 |
| 03:00 ET | 900 | 0.7531 |
| 03:09 ET | 490 | 0.7531 |
| 03:16 ET | 100 | 0.7532 |
| 03:18 ET | 1097 | 0.7511 |
| 03:23 ET | 100 | 0.7545 |
| 03:32 ET | 100 | 0.749 |
| 03:45 ET | 594 | 0.7517 |
| 03:57 ET | 13982 | 0.7585 |
| 03:59 ET | 12443 | 0.7517 |
Yesterday
May 23, 2024
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting, from 5:01PM ET on Thursday May 23, 2024 by Dow Jones
5:01PM ET on Thursday May 23, 2024 by Dow Jones
May 21, 2024
DJ HOOKIPA Pharma Price Target Maintained With a $5.00/Share by RBC Capital, from 1:21PM ET on Tuesday May 21, 2024 by Dow Jones
1:21PM ET on Tuesday May 21, 2024 by Dow Jones
May 9, 2024
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights, from 7:01AM ET on Thursday May 09, 2024 by Dow Jones
7:01AM ET on Thursday May 09, 2024 by Dow Jones*DJ HOOKIPA Pharma 1Q EPS 11c >HOOK, from 7:01AM ET on Thursday May 09, 2024 by Dow Jones
7:01AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
HOOKIPA Pharma Inc | 74.4M | 0.0x | --- |
Company Information
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. HB-700 is in preclinical development for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers. Its Hepatitis B (HBV) program, HB-400, and its Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in a partnership with Gilead Sciences, Inc.
Contact Information
- Headquarters
- 350 Fifth Avenue, 72Nd Floor, Suite 7240NEW YORK, NY, United States 10118
- Phone
- ---
- Fax
- 302-655-5049
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $74.4M |
|---|---|
Revenue (TTM) | $53.6M |
Shares Outstanding | 99.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-0.59 |
Book Value | $0.91 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -119.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
